CG Oncology Inc.
Status: Publicly traded
Direct answer
CG Oncology Inc. is publicly traded on NASDAQ under the ticker CGON.
CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company’s product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to...
Can you invest in CG Oncology Inc.?
Yes. CG Oncology Inc. trades publicly on NASDAQ as CGON.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for CG Oncology Inc.
Detailed equity research is provided by MarketSnap.